SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Jul. 31, 2024	Jul. 24, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average basic common shares (in shares)	13,623,000	13,349,000	13,538,000	13,236,000
Effect of stock options (in shares)	2,000	0	0	0
Effect of dilutive share awards (in shares)	363,000	0	305,000	0
Weighted average diluted common shares (in shares)	13,988,000	13,349,000	13,843,000	13,236,000
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)		200,000
Aggregate shares to be sold, maximum					$ 50.0
Common stock repurchases
Repurchased shares of common stock under stock repurchase program (in shares)			0	0
Remaining authorized repurchase amount	$ 96.7		$ 96.7
2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%	0.50%	0.50%	0.50%
Convertible Debt | 2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%		0.50%			0.50%
Option
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	800,000	900,000	900,000	900,000
Restricted Stock Units (RSUs)
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	0	100,000	0	100,000
Convertible Debt
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	200,000	300,000	300,000	600,000